Bionure


Bionure is a late-preclinical company focused at developing First-in-Class SGK agonists for the treatment of rare ophthalmology diseases.

Employees

1-10

Links


Org chart

Carmen Sanfrancisco
CEO - Consejera delegada
Collapse
Ricard Mis
Scientific Director
Pascal Nizet
Partner And Secretary Of The Board
Salut Monràs
Private Investor With Valrà Finances S.l.

Teams

This company has no teams yet


Offices